Abstract:Structure-activity relationship (SAR) studies of numerous opioid ligands have shown that introduction of a methyl or ethyl group on the tertiary amino group at position 17 of the epoxymorphinan skeleton generally results in a mu opioid receptor (MOR) agonist while introduction of a cyclopropylmethyl group typically leads to an antagonist. Furthermore, it has been shown that introduction of heterocyclic ring systems at position 6 can favor antagonism. However, it was reported that 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(2'-indolyl)acetamido]morphinan (INTA), which bears a cyclopropylmethyl group at position 17 and an indole ring at position 6, acted as a MOR agonist. We herein report a SAR study on INTA with a series of its complementary derivatives to understand how introduction of an indole moiety with α or β linkage at position 6 of the epoxymorphinan skeleton may influence ligand function. Interestingly, one of INTA derivatives, compound 15 (NAN) was identified as a MOR antagonist both in vitro and in vivo. Molecular modeling studies revealed that INTA and NAN may interact with different domains of the MOR allosteric binding site. In addition, INTA may interact with W293 and N150 residues found in the orthosteric site to stabilize MOR activation conformation while NAN does not. These results suggest that INTA and NAN may be bitopic ligands and the type of allosteric interactions with the MOR influence their functional activity. These insights along with our enriched comprehension of the "message-address" concept will to benefit future ligand design.

Design, Synthesis And 3d-Qsar Study Of N-Substituted-3-Indolyl-Acetamide Series As Alpha(1)-Adrenoceptor Antagonists

Design, Synthesis And 3d-Qsar Study Of 2-[N '-(2-Aryloxyethyl)Piperazinomethyl]-Benzoxazole Series As Alpha(1)-Adrenoceptor Antagonists

Synthesis and Biological Activity of N-substituted-3-indolylacetamide Series As Α_1-Adrenoceptor Antagonists

Design, Synthesis And Biological Activity Study On N-[4-(Substituted Phenyl)Piperazine-1-Yl]Alkyl Amide Series As Alpha(1)-Adrenoceptor Antagonists

Design, Synthesis, And Sar Studies Of Heteroarylpyrimidines And Heteroaryltriazines As Cb2r Ligands

Rational Design, Synthesis, Biologic Evaluation, and Structure–activity Relationship Studies of Novel 1‐indanone Α1‐adrenoceptor Antagonists

Study on three-dimensional quantitative structure-activity relationships of N-sub tituted-4-subtituted phenylpiperazine-1-acetic amide series as α1- adrenoceptor antagonists

Design and synthesis of novel 3-substituted-indole derivatives as selective H3 receptor antagonists and potent free radical scavengers.

Synthesis, biological evaluation and 3D-QSAR study of 1-(1,4-benzodioxan-2-ylcaronyl)-4-aryloxyalkyl-piperazines as α1-adrenoceptor antagonists

X-ray Crystallography, DFT Calculations and Molecular Docking of Indole-Arylpiperazine Derivatives As Α1a-Adrenoceptor Antagonists

Searching for the Novel Lead Compounds of alpha(1)-AR Antagonists (Part I): Design, Synthesis and Bioassay of 5-Chloro-2-[4-(aryloxyalkyl)piperazin-1-yl] benzo[d]oxazole Compounds

Design, Synthesis and Biological Estimation of 1-(Benzoxazole-2-yl)piperazine and 4-(Benzoxazole-2-yl)piperidine Derivatives As Potential Α1-Ar Antagonists

Computational Studies of the Binding Site of Α 1A -Adrenoceptor Antagonists

Design, Synthesis, Crystal Structure, Biological Evaluation and Molecular Docking Studies of Carbazole-Arylpiperazine Derivatives.

Structure activity relationship studies of 6α- and 6β-indolylacetamidonaltrexamine derivatives as bitopic mu opioid receptor modulators and elaboration of the 'message-address concept' to comprehend their functional conversion.

Design,synthesis and biological activities of 1-(5- t -butyl-2-benzoxazolemethyl)-4-aryloxyalkyl-piperazine as α1 adrenoceptor antagonists

Synthesis and Biological Activity of 1-(1,4-benzodioxan-2-yl-carbonyl)-4-aryloxy-alkyl-piperazine As Α_1-Adrenoceptor Antagonists

Synthesis and blocking activities of a new class of α₁-adrenoceptor antagonists.

Synthesis, Crystal Structure, Biological Evaluation, and Molecular Docking Studies of Quinoline-Arylpiperazine Derivative As Potent Α1a-Adrenoceptor Antagonist

Studies On Synthesis And Biological Activity Of Pyridazinone Derivatives As Alpha(1)-Adrenoceptor Antagonist

Design and Synthesis of Novel Aryloxyalkyl-Arylpiperazine Derivatives As Alpha(1a)-Adrenoceptor Antagonists